Hope for Less Than 50 Cents a Dose: A Revolutionary Model for Developing Low-Cost Vaccines

This fact sheet describes the model employed by the Meningitis Vaccine Project to develop a safe, affordable, and long-lasting vaccine with the potential to end Group A meningococcal epidemics in Africa, as well as the contributions of many key partners who made the development of MenAfriVac™ such a success story.

Publication date: September 2011

Hope for Less Than 50 Cents a Dose

1.4 MB PDF
Hard copies are not available.
View Resource